Defining new epigenetic gene silencing axis driving repeat-associated heterochromatin formation in Friedreich’s Ataxia patients’ cells
Does Frataxin Deficiency Disrupt GluR2 Trafficking in the Cerebellum via Defects in Palmitoylation?
Preclinical evaluation of novel targets for FRDA cardiomyopathy
Shortening GAA repeats in Friedreich’s Ataxia
NRF2 and MAO-Ai therapy to improve cardiac health and prevent arrhythmias in Friedreich’s ataxia
Deciphering the neurodevelopmental component in Friedreich Ataxia
Elucidation of the peripheral immune axis in FRDA and identification of blood-based biomarkers of inflammation
Population and cellular heterogeneity in Friedreich Ataxia
Investigating the effects of frataxin deficiency on the human proteome